We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,615

Food & Beverage Litigation Update: Issue 634
  • Shook Hardy & Bacon LLP
  • European Union, USA
  • May 12 2017

The U.S. Senate has confirmed Scott Gottlieb to lead the Food and Drug Administration (FDA) in


FDA refuses to re-classify tooth-whitening products as drugs
  • Shook Hardy & Bacon LLP
  • USA
  • May 2 2014

The U.S. Food and Drug Administration (FDA) has denied a Citizen Petition asking the agency to re-categorize tooth-whitening products as drugs


FDA issues final rule on mica-based pearlescent pigments in distilled spirits
  • Shook Hardy & Bacon LLP
  • USA
  • October 2 2015

The U.S. Food and Drug Administration (FDA) has issued a final rule allowing "the safe use of mica-based pearlescent pigments prepared from titanium


FDA steps up issuance of warning letters to cosmetic and dietary supplement companies
  • Shook Hardy & Bacon LLP
  • USA
  • April 1 2015

The Food and Drug Administration (FDA) has issued a number of Warning Letters to cosmetic and dietary supplement companies over the last several


Impact of SSB taxes on employment disputed in new study
  • Shook Hardy & Bacon LLP
  • USA
  • February 21 2014

Researchers with the University of Illinois, Chicago, Institute for Health Research and Policy have published a study allegedly concluding that


Pelman v. McDonald’s Corp.: no class certification for obese teens
  • Shook Hardy & Bacon LLP
  • USA
  • October 29 2010

A judge from the U.S. Court of International Trade, sitting by designation in a New York federal district court, has determined that the obesity-related claims filed in 2002 against McDonald’s Corp. cannot be pursued as a class action


Landmark Texas Supreme Court decision: learned intermediary doctrine applies in prescription drug cases, no DTC exception
  • Shook Hardy & Bacon LLP
  • USA
  • June 12 2012

Addressing the issue squarely for the first time, the Texas Supreme Court has unanimously adopted the learned intermediary doctrine in the prescription drug context thereby confirming that manufacturers are only obligated to warn doctors of the risks of prescription medicines


DMAA cleared as cause of soldiers’ deaths
  • Shook Hardy & Bacon LLP
  • USA
  • August 15 2013

A safety review panel formed by the U.S. Army and Department of Defense (DOD) has issued a report which concludes that although DMAA (1


Does consumer awareness of food addiction affect eating behavior?
  • Shook Hardy & Bacon LLP
  • USA
  • April 24 2015

Raising concerns about how the media portrays the concept of food addiction, a new study questions whether endorsement of this model "may cause


FDA announces new adverse event reporting portal for dietary supplements
  • Shook Hardy & Bacon LLP
  • USA
  • January 24 2014

The U.S. Food and Drug Administration (FDA) has announced that "in the interest of efficiency and as a convenience to dietary supplement manufac-